1. Scrip
  2. >>Focus On Asia

Sanofi Goes Big On Asia Vaccines With Singapore Investment

Flexibility, Demand, Preparedness Cited

 
• By Ian Haydock

French giant makes its biggest single investment to date in Asia as it prepares to build up regional vaccine production capacity, in part to help prepare for future pandemics. 

Sanofi Singapore Vaccines Facility Event
L-R: Dr Beh Swan Gin, Chairman, Singapore Economic Development Board; Vincent Hingot, SVP, Head of Global Vaccines Industrial Affairs, Sanofi Pasteur; Eric Mansion, General Manager, Asia Zone, Sanofi Pasteur • Source: Sanofi

Sanofi says its €400m ($475m) investment in a new vaccine production facility in Singapore aims to create a regional center for the simultaneous manufacturing of multiple products, for supply mainly to Asian markets but potentially beyond.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Focus On Asia

More from Scrip